No Data
Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SH) announced equity distribution for the first three quarters of 2024: dividend of 0.26 yuan per share, with equity registration on November 14th.
Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SH) announced the equity distribution notice for the first three quarters of 2024, and the profit distribution for this time is based on the plan...
Solid Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)
Gibbel: Q3 2024 Report
Gibel 2024 Third Quarter Report
jiangsu jibeier pharmaceutical co., ltd. (688566.SH): net income of 0.175 billion yuan in the first three quarters, a year-on-year increase of 12.57%.
Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SH) announced that in the first three quarters of 2024, it achieved revenue of 0.643 billion yuan, a year-on-year increase of 4.25%; net income attributable to shareholders of the listed companies was 0.175 billion yuan, an increase of 12.57% year-on-year, with basic earnings per share of 0.91 yuan.
Further Upside For Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHSE:688566) Shares Could Introduce Price Risks After 38% Bounce
Could The Market Be Wrong About Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHSE:688566) Given Its Attractive Financial Prospects?No Data
No Data
